| Document |
Document Title |
|
WO/2024/110393A1 |
The present invention relates to a method and apparatus for determining a correction term for a color prediction model to allow reliable color prediction and color matching operations using input data being determined under different phy...
|
|
WO/2024/110960A1 |
A system and methods thereof that allow for real-time monitoring of cell-to-cell interactions of biological cells. The method: receives a first image of a multiwell carrier chip, where at least one well contains cells of a first type; pe...
|
|
WO/2024/110749A1 |
The present invention relates to methods for determining the health status of populations of fish and diagnosing conditions or diseases in unhealthy fish. In particular, the present invention relates to blood biomarkers for assessing the...
|
|
WO/2024/112121A1 |
The present invention relates to artificial intelligence software for reading an image of gastric cancer pathological tissue, the artificial intelligence software comprising: an input unit for inputting H&E stained whole slide images (WS...
|
|
WO/2024/110621A1 |
The present invention relates to the preparation of milk samples with bile salts and lipase to allow the detection of analytes and/or pathogens.
|
|
WO/2024/112941A1 |
Autonomic dysfunction has been implicated in the pathophysiology of sudden infant death syndrome (SIDS). Butyrylcholinesterase is an enzyme of the cholinergic system, a major branch of the autonomic system and can be used as a measure of...
|
|
WO/2024/086692A3 |
The present disclosure relates to compositions and methods for the treatment of neurological disorders.
|
|
WO/2024/111921A1 |
The present invention relates to a method for providing muscle cell-based diagnostic criteria for sarcopenia diagnosis, the method comprising the steps of: identifying levels of the increase or decrease in muscle cell quantity varying de...
|
|
WO/2024/112912A1 |
A cell culture system includes one or more scaffold cups comprising a cell-compatible material and a ring defining a periphery of the one or more scaffold cups, wherein the cell-compatible material is adhered over an aperture of the ring...
|
|
WO/2024/111627A1 |
A method for evaluating an oxidation risk of a separation membrane in a water treatment plant, the method being characterized by collecting a deposit adherent to a separation membrane which has been used, bringing the deposit into contac...
|
|
WO/2024/108604A1 |
A blood metabolite-based neurodegenerative disease marker and the use thereof. The biomarker comprises any one or a plurality of: N-acetyl-L-tyrosine, ornithine, L-cystine, L-histidine, carboxymethyl cysteine, 7-dehydrocholic acid, β-hy...
|
|
WO/2024/111665A1 |
In the case of detecting bacteria having different bacteriolysis targets, it is necessary to separately perform bacteriolysis for each bacteriolysis target by employing a bacteriolysis solution containing a bacteriolytic enzyme suitable ...
|
|
WO/2024/111781A1 |
An electronic device for measuring water quality of influent sewage comprising: a sensor unit installed inside an influent sewage pipe and including at least one sensor that measures water quality items of the influent sewage and outputs...
|
|
WO/2024/086745A3 |
The present disclosure provides systems and methods for analyzing or identifying a target nucleic acid molecule. For example, a system of the present disclosure may comprise (a) a complex comprising a target nucleic acid molecule and a p...
|
|
WO/2024/110685A1 |
The invention provides a sensor for detecting mercaptans in wines that comprises a screen-printed carbon electrode modified with cobalt phthalocyanine, specifically for detecting the organoleptic defect associated with the presence of me...
|
|
WO/2024/110656A1 |
The present disclosure relates to a device, a kit and a method for image guided stereotaxic sampling and oriented sectioning of a biological specimen for correlating 3D medical imaging to spatial transcriptomics. One embodiment relates t...
|
|
WO/2024/112779A1 |
Disclosed are leave-one-out GFP (LOO_GFP) biosensors immobilized in Ubx (Drosphila protein Ultrabithorax) that form immobilized and stabilized fluorescent protein biosensor systems (LOO_GFP-Ubx systems). These LOO_GFP-Ubx systems have an...
|
|
WO/2024/112303A1 |
The invention relates to a portable plasmonic biosensor system to be used in the diagnosis of FMF (Familial Mediterranean Fever) disease.
|
|
WO/2024/108603A1 |
The present invention relates to the technical field of biology, and in particular to a fecal metabolite-based neurodegenerative disease marker, and the use thereof. A biomarker provided by the solution has the characteristics of high se...
|
|
WO/2024/112158A1 |
The present invention relates to an immunotherapeutic anticancer agent evaluation platform using a cancer patient immune-mimicking avatar system. The gastric cancer patient mimicking avatar model of the present invention was found to acc...
|
|
WO/2024/108597A1 |
A dry chemical testing apparatus and a dry chemical testing method. The method comprises: after a biological sample to be tested is added to a target color block (99) of a first dry chemical test strip (91) by a sample adding component (...
|
|
WO/2024/110591A1 |
The invention is based on a novel technology to identify inflammatory responsive elements (IREs) in a mesenchymal stromal cell (MSC) culture that allowed for the development of biomarkers, in particular CD55, CD146, CD271 and MSCA-1, or ...
|
|
WO/2024/110088A1 |
A method for analyzing a sample is provided, the sample comprising a plurality of affinity reagents (5302a), each affinity reagent (5302a) being configured to attach to an analyte (900), at least one of the affinity reagents (5302a) bein...
|
|
WO/2024/092121A3 |
Systems and methods are described herein enabling the profiling of local microenvironments across the sialylated proteome via proximity labeling. In one aspect, conjugates are described herein having composition and electronic structure ...
|
|
WO/2024/112204A1 |
A device (10a; 10b; 30) for measuring a first pressure (PO) in a first fluid and a second pressure (PW) in a second fluid, at a location in a hydrocarbon zone (ZO) in a subterranean formation (9) comprises a water-filled system with a pr...
|
|
WO/2024/086741A3 |
The present disclosure relates to polypeptides, such as fibronectin type III (FN3) domains that can bind CD71, their conjugates, isolated nucleotides encoding the molecules, vectors, host-cells, as well as methods of making and using the...
|
|
WO/2023/195805A3 |
The present invention relates to a drug delivery system that specifically binds to integrin beta 2 (ITGB2) on M2 tumor-associated macrophages. The drug delivery system comprising an ITGB2-binding moiety allowing specific binding to ITGB2...
|
|
WO/2024/108598A1 |
A dry-chemistry test apparatus and method. The test apparatus comprises a bearing component (10), a sample adding component (30), an imaging component (50) and a processor (70), wherein the bearing component (10) is configured for placem...
|
|
WO/2024/077281A3 |
The present disclosure provides in vitro assays for genotyping a porcine reproductive and respiratory syndrome virus (PRRSV). Methods and kits for the in vitro assays are also provided.
|
|
WO/2024/073664A3 |
This application relates to, in part, modified Botulinum Neurotoxins (BoNTs) comprising modified BoNT/A2 receptor binding domains with increased receptor binding activity, and methods of treatment using the modified BoNT.
|
|
WO/2024/112907A1 |
Disclosed herein are methods for detecting target protein interactions in a biological sample. Kits for carrying out the methods are also provided.
|
|
WO/2024/109324A1 |
A calibration platform for a transformer oil multi-parameter sensing device. The calibration platform comprises a standard new oil cup (1), an aged oil sample cup (2), a standard substance sample cup (3), a first straight-through valve (...
|
|
WO/2024/044308A3 |
Provided herein are methods for determining whether a drug impacts ubiquitination of G-coupled protein receptors (GPCRs) and the downstream transducer-mediated signaling of the GPCRs. Also provided are proteins, nucleic acids, vectors, c...
|
|
WO/2024/109591A1 |
A protein-coated magnetic bead comprising a magnetic base sphere unit; a protein or polypeptide unit; a polyethylene glycol chain, wherein one end of the polyethylene glycol chain is connected to the magnetic base sphere unit by means of...
|
|
WO/2024/110683A1 |
The present invention proposes the in vitro use of anti-SSA antinuclear antibodies in urine as an early biomarker for diagnosing and/or predicting kidney damage caused by Sjögren's syndrome.
|
|
WO/2024/064885A3 |
A controller includes a processor and a memory storing instructions configured to cause the processor to receive emission test data of a test aerosolization system corresponding to a test aerosolizer power or a range of test aerosolizer ...
|
|
WO/2024/073650A3 |
A synovium on a chip device having: a cartridge housing, a central chamber embedded in the cartridge housing, at least one aperture fluidly connected to the central chamber, and a plurality of evenly spaced micropillars arranged in a sub...
|
|
WO/2024/110700A1 |
Disclosed is a device, preferably for the thermodynamic characterization of a fluid, comprising a mobile structure, a fixed structure (5) and a system for actuating the mobile structure. The actuation system comprises a lever arm (55) co...
|
|
WO/2024/112874A1 |
Described herein are devices, systems, methods, and kits for use in the magnetic separation of biological entities from fluid samples.
|
|
WO/2023/056424A9 |
Embodiments described herein generally relate to systems and methods for processing mass spectrometry samples. Aspects of the disclosure include systems and methods for processing samples. Additionally, embodiments of the disclosure can ...
|
|
WO/2024/110181A1 |
The present invention relates to a method for determining flocculation conditions in a hydrocarbon fluid, according to which a flocculation model is applied to the hydrocarbon fluid, as well as a compositional model. Next, flocculation p...
|
|
WO/2024/110472A1 |
The invention is directed to a process analyzing arrangement (10) for continuously determining a water parameter of water (14) of a stationary water site (12), with an automatic analyzer unit (100) and a water sample feed pump (30) for p...
|
|
WO/2024/108700A1 |
A biomarker combination in exhaled breath and a use thereof in a novel coronavirus diagnostic reagent. The marker combination comprises some or all of biomarkers A, B, C, D, E, each of which separately corresponds to a characteristic mas...
|
|
WO/2024/076801A3 |
A method and corresponding kit for detecting Sjögren's Disease or predicting labial salivary gland biopsy results. The method includes evaluating an individual for the presence of one or more peptides or whole proteins or fragments ther...
|
|
WO/2024/110698A1 |
The invention relates to a device for thermodynamic characterisation of a fluid, comprising a seal (31) for sealing a piston, the seal (31) comprising a stack of rings (71-75). The invention also relates to a method for mounting such a s...
|
|
WO/2024/110961A1 |
A system and methods thereof for selection of biological cells within wells of a multiwell chip (MWC). The method: receives a first image of the wells of the MWC, where some wells are occupied by cells of a first type; performs image pro...
|
|
WO/2024/109611A1 |
Provided is a mutant respiratory syncytial virus pre-fusion F protein, having the following mutations compared with a wild-type respiratory syncytial virus pre-fusion F protein: (a) at least one amino acid residue in an F1 subunit and/or...
|
|
WO/2024/081806A3 |
Provided are compositions and methods that relate to therapy of B cell diseases and include discovery of novel molecular heterogeneity of the signaling component (i.e., CD79) of human B cell antigen receptor (BCR). The method includes co...
|
|
WO/2024/086781A3 |
According to some aspects, systems and methods for characterizing phosphoserine-containing polypeptides are described. In some embodiments, a phosphoserine residue of a polypeptide may be converted to a dehydroalanine residue. Some aspec...
|
|
WO/2024/112940A1 |
Described herein are methods for identifying components of a protein-protein complex and methods for identifying one or more compounds that cause protein complex formation, stabilization, or dissociation. Also described are systems for p...
|
